Ketamine infusions for treatment resistant depression: A series of 28 patients treated weekly or twice weekly in an ECT clinic

Journal of Psychopharmacology

Volumn 28, Issue 6, 2014, Pages 536-544

  Diamond, Peter R ^a   Farmery, Andrew D ^b   Atkinson, Stephanie ^a   Haldar, Jag ^c   Williams, Nicola ^b   Cowen, Phil J ^d   Geddes, John R ^d   McShane, Rupert ^a,d  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c OXFORD UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^d UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antidepressant; ketamine; memory; treatment resistant depression

Indexed keywords

KETAMINE; ANTIDEPRESSANT AGENT;

ADULT; ANXIETY DISORDER; ARTICLE; AUTOBIOGRAPHICAL MEMORY; BIPOLAR DEPRESSION; CASE STUDY; CLINICAL ARTICLE; CLINICAL TRIAL; CONFUSION; DETACHMENT, ANXIETY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ELECTROCONVULSIVE THERAPY; EPISODIC MEMORY; FATIGUE; FEMALE; HUMAN; HYPNAGOGIC HALLUCINATION; HYPOMANIA; LOW DRUG DOSE; MAJOR DEPRESSION; MALE; MEMORY; MEMORY DISORDER; MENTAL INSTABILITY; MOOD DISORDER; NAUSEA; OPEN STUDY; OUTCOME ASSESSMENT; PANIC; PATIENT MONITORING; PERCEPTION DISORDER; PRIORITY JOURNAL; RECALL; SUBJECTIVE MEMORY; SUICIDAL IDEATION; TACHYCARDIA; TACHYPNEA; TREATMENT DURATION; TREATMENT RESISTANT DEPRESSION; UPPER RESPIRATORY TRACT INFECTION; VOMITING; AFFECT; BRAIN; DRUG ADMINISTRATION; DRUG EFFECTS; INTRAVENOUS DRUG ADMINISTRATION; MIDDLE AGED; OUTPATIENT DEPARTMENT; PATHOPHYSIOLOGY; PSYCHOLOGY; TIME FACTOR; TREATMENT OUTCOME;

ADULT; AFFECT; ANTIDEPRESSIVE AGENTS; BRAIN; DEPRESSIVE DISORDER, TREATMENT-RESISTANT; DRUG ADMINISTRATION SCHEDULE; ELECTROCONVULSIVE THERAPY; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; KETAMINE; MALE; MEMORY; MIDDLE AGED; OUTPATIENT CLINICS, HOSPITAL; TIME FACTORS; TREATMENT OUTCOME;

EID: 84898003445     PISSN: 02698811     EISSN: 14617285     Source Type: Journal    
DOI: 10.1177/0269881114527361     Document Type: Article

References (24)

1. Aan het Rot M, Collins KA, Murrough JW, et al. Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression. Biol Psychiatry. 2010 ; 67: 139-145
2. Aan het Rot M, Zarate CA, Charney DS, et al. Ketamine for depression: where do we go from here?. Biol Psychiatry. 2012 ; 72: 537-547
3. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry. 1974 ; 7: 151-169
4. Berman RM, Cappiello A, Anand A, et al. Antidepressant effects of ketamine in depressed patients. Biol Psychiatry. 2000 ; 47: 351-354
5. Cunje A, Molloy DW, Standish TI, et al. Alternate forms of logical memory and verbal fluency tasks for repeated testing in early cognitive changes. Int Psychogeriatr. 2007 ; 19: 65-75
6. DiazGranados N, Ibrahim L, Brutsche NE, et al. A randomized add-on trial of an N-methyl-d-aspartate antagonist in treatment-resistant bipolar depression. Arch Gen Psychiatry. 2010 ; 67: 793-802
7. Dritschel BH, Williams JM, Baddeley AD, et al. Autobiographical fluency: a method for the study of personal memory. Mem Cognit. 1992 ; 20: 133-140
8. First M, Anthony JC, Tepper S, et al Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I/NP, Research Version, Non-patient Edition). New York: New York State Psychiatric Institute ; 1997 :
9. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 ; 23: 56-62
10. KershawKF (2010) The effects of depression and electroconvulsive therapy on autobiographical memory and cognitive function. PhD Thesis. Goldsmiths, University of London, UK.
11. Larkin GL, Beautrais AL. A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department. Int J Clin Neuropsych. 2011 ; 14: 1127-1131
12. Lisanby SH, Maddox JH, Prudic J, et al. The effects of electroconvulsive therapy on memory of autobiographical and public events. Arch Gen Psychiatry. 2000 ; 57: 581-590
13. McElhiney M, Moody B, Sackeim H The Autobiographical Memory Interview - Short Form. New York: New York State Psychiatric Institute ; 1997 :
14. Morgan CJA, Curran HV. Acute and chronic effects of ketamine upon human memory: a review. Psychopharmacology. 2006 ; 188: 408-424
15. Murrough JW, Iosifescu DV, Chang LC, et al. Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial. Am J Psychiatry. 2013 ; 170: 1134-1142
16. Murrough JW, Perez AM, Pillemer S, et al. Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression. Biol Psychiatry. 2013a ; 74: 250-256
17. Overall JE, Gorham DR. The Brief Psychiatric Rating Scale. Psychol Rep. 1962 ; 10: 799-812
18. Powell JH, Pickering AD, Wyke M, et al. The effects of three anti-hypertensive medications on learning and memory. Br J Pharmacol. 1993 ; 35: 105-113
19. Price RB, Nock MK, Charney DS, et al. Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression. Biol Psychiatry. 2009 ; 66: 522-526
20. Rush A, Trivedi M, Wisniewski S, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report. Am J Psychiatry. 2006 ; 163: 1905-1917
21. Sackeim HA. The definition and meaning of treatment-resistant depression. J Clin Psych. 2001 ; 62 (16). 10-17
22. Valentine GW, Mason GF, Gomez R, et al. The antidepressant effect of ketamine is not associated with changes in occipital amino acid neurotransmitter content as measured by [(1)H]-MRS. Psychiatry Res Neuroimaging. 2011 ; 191: 122-127
23. Zarate CA, Brutsche NE, Ibrahim L, et al. Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial. Biol Psychiatry. 2012 ; 71: 939-946
24. Zarate CA, Singh JB, Carlson PJ, et al. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch Gen Psychiatry. 2006 ; 63: 856-864